Wesbanco Bank Inc. raised its position in Align Technology, Inc. (NASDAQ:ALGN) by 0.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,054 shares of the medical equipment provider’s stock after buying an additional 100 shares during the period. Wesbanco Bank Inc.’s holdings in Align Technology were worth $1,659,000 as of its most recent filing with the SEC.

Several other large investors have also bought and sold shares of ALGN. Honkamp Krueger Financial Services Inc. raised its stake in Align Technology by 1.7% in the second quarter. Honkamp Krueger Financial Services Inc. now owns 2,037 shares of the medical equipment provider’s stock valued at $306,000 after buying an additional 34 shares during the period. Intellectus Partners LLC raised its stake in Align Technology by 1.2% in the first quarter. Intellectus Partners LLC now owns 3,498 shares of the medical equipment provider’s stock valued at $401,000 after buying an additional 41 shares during the period. Mn Services Vermogensbeheer B.V. raised its stake in Align Technology by 2.8% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 1,917 shares of the medical equipment provider’s stock valued at $206,000 after buying an additional 52 shares during the period. Buckingham Asset Management LLC raised its stake in Align Technology by 3.3% in the second quarter. Buckingham Asset Management LLC now owns 1,861 shares of the medical equipment provider’s stock valued at $279,000 after buying an additional 59 shares during the period. Finally, Security Asset Management raised its stake in Align Technology by 0.5% in the second quarter. Security Asset Management now owns 12,735 shares of the medical equipment provider’s stock valued at $1,912,000 after buying an additional 65 shares during the period. Institutional investors own 81.71% of the company’s stock.

Shares of Align Technology, Inc. (NASDAQ ALGN) opened at 175.09 on Thursday. The stock’s 50 day moving average is $165.44 and its 200 day moving average is $135.40. The stock has a market cap of $14.03 billion, a price-to-earnings ratio of 59.96 and a beta of 1.55. Align Technology, Inc. has a 52 week low of $83.27 and a 52 week high of $179.76.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.73 by $0.12. Align Technology had a net margin of 19.18% and a return on equity of 23.87%. The company had revenue of $356.50 million during the quarter, compared to analyst estimates of $343.43 million. During the same period last year, the firm posted $0.62 EPS. Align Technology’s revenue for the quarter was up 32.3% compared to the same quarter last year. On average, equities analysts forecast that Align Technology, Inc. will post $3.40 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Wesbanco Bank Inc. Has $1.66 Million Stake in Align Technology, Inc. (ALGN)” was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of US & international copyright law. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/wesbanco-bank-inc-has-1-66-million-stake-in-align-technology-inc-algn/1534147.html.

Several equities research analysts have commented on the stock. Leerink Swann reiterated an “outperform” rating and issued a $199.00 price objective (up previously from $194.00) on shares of Align Technology in a research note on Friday, July 28th. Stifel Nicolaus reiterated a “buy” rating and issued a $205.00 price objective (up previously from $200.00) on shares of Align Technology in a research note on Monday, August 7th. Zacks Investment Research lowered shares of Align Technology from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 21st. Piper Jaffray Companies reiterated a “buy” rating and issued a $176.00 price objective on shares of Align Technology in a research note on Friday, July 28th. Finally, Bank of America Corporation upgraded shares of Align Technology from a “neutral” rating to a “buy” rating and increased their price objective for the company from $175.00 to $193.00 in a research note on Friday, July 28th. One equities research analyst has rated the stock with a hold rating and nine have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $174.40.

Align Technology Company Profile

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.